4 départements de recherche
750 employés
45 nationalités
55 équipes de recherche
16 lauréats ERC
260 publications par an
24000 m² de laboratoires

Soutenez-nous via

Fondation universite de Strasbourg

Génomique fonctionnelle et cancer

  • Modeling gene-regulatory networks to describe cell fate transitions and predict master regulators.

    Cholley PE(1)(2), Moehlin J(1), Rohmer A(1), Zilliox V(1), Nicaise S(1), Gronemeyer H(1), Mendoza-Parra MA(1)(3).

    NPJ Syst Biol Appl 2 août 2018

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

    Galluzzi L(1)(2)(3), Vitale I(4)(5), Aaronson SA(6), Abrams JM(7), Adam D(8), Agostinis P(9), Alnemri ES(10), Altucci L(11), Amelio I(12), Andrews DW(13)(14)(15), Annicchiarico-Petruzzelli M(16), Antonov AV(12), Arama E(17), Baehrecke EH(18), Barlev NA(19), Bazan NG(20), Bernassola F(21), Bertrand MJM(22)(23), Bianchi K(24), Blagosklonny MV(25), Blomgren K(26)(27), Borner C(28)(29), Boya P(30), Brenner C(31)(32), Campanella M(4)(5)(33)(34), Candi E(16)(21), Carmona-Gutierrez D(35), Cecconi F(4)(36)(37), Chan FK(38), Chandel NS(39), Cheng EH(40), Chipuk JE(6), Cidlowski JA(41), Ciechanover A(42), Cohen GM(43), Conrad M(44), Cubillos-Ruiz JR(45)(46), Czabotar PE(47)(48), D'Angiolella V(49), Dawson TM(50)(51)(52)(53), Dawson VL(50)(51)(53)(54), De Laurenzi V(55), De Maria R(56), Debatin KM(57), DeBerardinis RJ(58), Deshmukh M(59), Di Daniele N(60), Di Virgilio F(61), Dixit VM(62), Dixon SJ(63), Duckett CS(64), Dynlacht BD(65)(66), El-Deiry WS(67)(68), Elrod JW(69), Fimia GM(70)(71), Fulda S(72)(73)(74), Garcia-Saez AJ(75), Garg AD(9), Garrido C(76)(77)(78), Gavathiotis E(79)(80)(81)(82), Golstein P(83), Gottlieb E(42)(84), Green DR(85), Greene LA(86), Gronemeyer H(87)(88)(89)(90), Gross A(91), Hajnoczky G(92), Hardwick JM(93), Harris IS(94), Hengartner MO(95), Hetz C(96)(97)(98), Ichijo H(99), Jaattela M(100), Joseph B(101), Jost PJ(102), Juin PP(103)(104)(105)(106), Kaiser WJ(107), Karin M(108)(109)(110)(111), Kaufmann T(112), Kepp O(113)(114)(115)(116)(117)(118), Kimchi A(17), Kitsis RN(80)(81)(82)(119)(120), Klionsky DJ(121)(122), Knight RA(12), Kumar S(123), Lee SW(124), Lemasters JJ(125)(126), Levine B(127)(128)(129), Linkermann A(130), Lipton SA(131)(132)(133), Lockshin RA(134)(135), Lopez-Otin C(136), Lowe SW(137)(138), Luedde T(139), Lugli E(140)(141), MacFarlane M(12), Madeo F(35)(142), Malewicz M(12), Malorni W(143), Manic G(4)(5), Marine JC(144)(145), Martin SJ(146), Martinou JC(147), Medema JP(148)(149), Mehlen P(150)(151)(152)(153)(154)(155), Meier P(156), Melino S(157), Miao EA(158)(159)(160), Molkentin JD(161), Moll UM(162), Munoz-Pinedo C(163), Nagata S(164), Nunez G(165)(166), Oberst A(167)(168), Oren M(169), Overholtzer M(170), Pagano M(66)(171)(172), Panaretakis T(173)(174), Pasparakis M(175)(176), Penninger JM(177), Pereira DM(178), Pervaiz S(179)(180)(181), Peter ME(182)(183), Piacentini M(4)(70), Pinton P(61)(184)(185), Prehn JHM(186), Puthalakath H(187), Rabinovich GA(188)(189), Rehm M(190)(191), Rizzuto R(192), Rodrigues CMP(193), Rubinsztein DC(194), Rudel T(195), Ryan KM(84), Sayan E(196), Scorrano L(197)(198), Shao F(199), Shi Y(200)(201)(202), Silke J(48)(203), Simon HU(112), Sistigu A(56)(204), Stockwell BR(205)(206), Strasser A(47), Szabadkai G(192)(207)(208), Tait SWG(84), Tang D(209)(210)(211)(212)(213)(214), Tavernarakis N(215), Thorburn A(216), Tsujimoto Y(217), Turk B(218)(219), Vanden Berghe T(22)(23), Vandenabeele P(22)(23), Vander Heiden MG(220)(221)(222), Villunger A(223), Virgin HW(224), Vousden KH(208), Vucic D(225), Wagner EF(226), Walczak H(227), Wallach D(228), Wang Y(229), Wells JA(230), Wood W(231), Yuan J(94)(232), Zakeri Z(233), Zhivotovsky B(101)(234), Zitvogel L(114)(235)(236)(237), Melino G(12)(21), Kroemer G(238)(239)(240)(241)(242)(243)(244).

    Cell Death Differ 23 janvier 2018

  • Oncological safety of nipple-sparing prophylactic mastectomy: A review of the literature on 3716 cases.

    Muller T(1), Baratte A(1), Bruant-Rodier C(1), Bodin F(1), Mathelin C(2).

    Ann Chir Plast Esthet Jun 2018

  • PFN2a, a new partner of RARalpha in the cytoplasm.

    Andriamoratsiresy D(1), Piskunov A(2), Lutzing R(1), Rochette-Egly C(3).

    Biochem Biophys Res Commun 1 janvier 2018

  • PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo.

    Parisotto M(1), Grelet E(1), El Bizri R(1), Dai Y(1), Terzic J(1), Eckert D(1), Gargowitsch L(1), Bornert JM(1), Metzger D(2).

    J Exp Med 4 juin 2018

  • Requirement of GSK-3 for PUMA induction upon loss of pro-survival PI3K signaling.

    Schubert F(1)(2)(3), Rapp J(1)(3), Brauns-Schubert P(1)(2)(3)(4), Schlicher L(1)(2)(3)(4), Stock K(1)(3), Wissler M(1), Wei M(1), Charvet C(5), Borner C(1)(2)(4), Maurer U(6)(7)(8).

    Cell Death Dis 23 avril 2018

  • Roles of activating functions 1 and 2 of estrogen receptor alpha in lymphopoiesis.

    Andersson A(1), Tornqvist AE(2), Moverare-Skrtic S(2), Bernardi AI(3), Farman HH(2), Chambon P(4), Engdahl C(3)(2), Lagerquist MK(2), Windahl SH(2), Carlsten H(3), Ohlsson C(2), Islander U(3).

    J Endocrinol Feb 2018

  • RORalpha-expressing T regulatory cells restrain allergic skin inflammation.

    Malhotra N(1), Leyva-Castillo JM(1), Jadhav U(2)(3), Barreiro O(4), Kam C(5), O'Neill NK(2)(3), Meylan F(6), Chambon P(7), von Andrian UH(4), Siegel RM(6), Wang EC(8), Shivdasani R(2)(3), Geha RS(1).

    Sci Immunol 2 mars 2018

Imprimer Envoyer

Université de Strasbourg
INSERM
CNRS

IGBMC - CNRS UMR 7104 - Inserm U 1258
1 rue Laurent Fries / BP 10142 / 67404 Illkirch CEDEX / France Tél +33 (0)3 88 65 32 00 / Fax +33 (0)3 88 65 32 01 / directeur.igbmc@igbmc.fr